Proliferation and differentiation of rat osteoporosis mesenchymal stem cells (MSCs) after telomerase reverse transcriptase (TERT) transfection

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Chao LiLiang Xu

Abstract

The aim of this study was to determine whether MSC are excellent materials for MSCs transplantation in the treatment of osteoporosis. We studied normal, osteoporosis, and TERT-transfected MSC from normal and osteoporosis rats to compare the proliferation and osteogenic differentiation using RT-PCR and Western blot by constructing an ovariectomized rat model of osteoporosis (OVX). The primary MSC from model rats were extracted and cultured to evaluate the proliferation and differentiation characteristics. MSCs of osteoporosis rats obviously decreased in proliferation ability and osteogenic differentiation compared to that of normal rats. In contrast, in TERT-transfected MSC, the proliferation and differentiation ability, and especially the ability of osteogenic differentiation, were significantly higher than in osteoporosis MSC. TERT-transfected MSCs can help osteoporosis patients in whom MSC proliferation and osteogenic differentiation ability are weak, with an increase in both bone mass and bone density, becoming an effective material for autologous transplantation of MSCs in further treatment of osteoporosis. However, studies are still needed to prove the in vivo effect, biological safety, and molecular mechanism of TERT-oste...Continue Reading

References

Mar 1, 1992·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M D GrynpasJ M Very
Oct 28, 1999·Journal of Cellular Biochemistry·J P RodríguezG Seitz
Jun 22, 2002·Nature·Yuehua JiangCatherine M Verfaillie
Jul 25, 2003·The Journal of Laboratory and Clinical Medicine·Emma Khan, Yousef Abu-Amer
Feb 26, 2004·Experimental Cell Research·Lin LiuDavid L Keefe
Feb 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Christina N BennettOrmond A MacDougald
Oct 21, 2005·Cytotherapy·E M HorwitzUNKNOWN International Society for Cellular Therapy
Dec 3, 2005·The Journal of Clinical Investigation·Lawrence G Raisz
Jan 3, 2006·Transplantation Proceedings·M J GimenoF J Blanco
Dec 6, 2006·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Russel BurgeAnna Tosteson
Apr 20, 2007·Annals of the New York Academy of Sciences·Willem E FibbeHelene Roelofs
Aug 8, 2007·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Weimin QiuMoustapha Kassem
Nov 2, 2007·Journal of Cellular Biochemistry·Pablo AstudilloJ Pablo Rodríguez
Mar 15, 2008·Biochemical and Biophysical Research Communications·Yan-Min ZhaoHe Huang
Aug 12, 2009·Vox Sanguinis·L SensebéR Giordano
Aug 12, 2009·Transplantation·Hiroyuki NakaharaNaoya Kobayashi
Sep 18, 2009·Annals of the New York Academy of Sciences·Susumu Ikehara
Feb 11, 2011·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Hamid SaeedMoustapha Kassem
Jan 1, 2013·Molecular Biology Reports·Fatemeh Jamshidi AdeganiMasoud Soleimani
Jan 4, 2013·Biological Research·Ana María PinoJ Pablo Rodríguez
Jun 29, 2013·Methods in Molecular Biology·Rony Atoui, Ray C J Chiu
Nov 26, 2013·Journal of Biomedical Nanotechnology·Amit K JaiswalJayesh R Bellare
Jan 11, 2014·Current Osteoporosis Reports·Ben AntebiDan Gazit
Aug 29, 2014·Arquivos brasileiros de endocrinologia e metabologia·Francisco BandeiraJohn P Bilezikian
Nov 27, 2014·World Journal of Stem Cells·Justin D Glenn, Katharine A Whartenby

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
X ray
PCR
fluorescence microscopy
flow cytometry

Software Mentioned

SPSS statistics
Scion Image

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.